Do caffeine and more selective adenosine A2A receptor antagonists protect against dopaminergic neurodegeneration in Parkinson's disease? is a research paper published in Parkinsonism & Related Disorders (2020). On theSindex it has a DataRank of 0.550. It has been cited 38 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.550
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIEHS NIH HHS
Grant: R01 ES010804
NINDS NIH HHS
Grant: R13 NS055597
NINDS NIH HHS
Grant: K24 NS060991
NINDS NIH HHS
Grant: R01 NS110879
NIDA NIH HHS
Grant: R01 DA013508
NINDS NIH HHS
Grant: R01 NS054978
National Institutes of Health
Grant: 5R01NS110879-05
Urate-LRRK2 interactions in Parkinson's disease
National Institute of Neurological Disorders and Stroke
Fields of Study
MeSH Terms
Keywords